Combination of transcatheter arterial chemo-embolization and percutaneous microwave coagulation therapy in the treatment of hepatocellular carcinoma
Jinxin Liu
Abstract
Jinxin Liu
Abstract
Objective To investigate the efficacy and safety of combination of transcatheter arterial chemo-embolization (TACE) and percutaneous microwave coagulation therapy (PMCT) in treatment of hepatocellular carcinoma (PHC).Methods 82 cases of PHC were divided into combined group (TACE+PMCT,n=45) and control group (only TACE,n=37).Patients were followed up for 1 to 2 years,and the therapeutic effects and side effects were compared between the two groups.Results The patients with tumor completely necrosis and AFP level lower than 50% in combined group were significantly more than those in control group (P0.05);the one year and two years survival rate in combined group were greatly higher than those of control group,and the recurrence rate was lower than control group;no severe side effect was observed in two groups.Conclusion TACE+PMCT is effective and safe in treatment of PHC of more than 3 cm in diameter.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the efficacy and safety of combination of transcatheter arterial chemo-embolization (TACE) and percutaneous microwave coagulation therapy (PMCT) in treatment of hepatocellular carcinoma (PHC).Methods 82 cases of PHC were divided into combined group (TACE+PMCT,n=45) and control group (only TACE,n=37).Patients were followed up for 1 to 2 years,and the therapeutic effects and side effects were compared between the two groups.Results The patients with tumor completely necrosis and AFP level lower than 50% in combined group were significantly more than those in control group (P0.05);the one year and two years survival rate in combined group were greatly higher than those of control group,and the recurrence rate was lower than control group;no severe side effect was observed in two groups.Conclusion TACE+PMCT is effective and safe in treatment of PHC of more than 3 cm in diameter.
Key concepts: Medicine, Hepatocellular carcinoma, Percutaneous, Arterial Embolization, Embolization, Transcatheter arterial chemoembolization, Surgery, Therapeutic effect